# The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China

> **NCT04286841** · — · RECRUITING · sponsor: **Guangdong Association of Clinical Trials** · enrollment: 100 (estimated)

## Conditions studied

- Immunotherapy
- Lung Cancer

## Interventions

- **DRUG:** Immunotherapy

## Key facts

- **NCT ID:** NCT04286841
- **Lead sponsor:** Guangdong Association of Clinical Trials
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-05-01
- **Primary completion:** 2022-12
- **Final completion:** 2029-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04286841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04286841, "The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT04286841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*